Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 21 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Autologous Induced Pluripotent Stem Cells of Cardiac Lineage Delivered Into Heart Muscle for Congenital Heart Disease

    Rochester, MN

  2. A Study to Evaluate a Computerized Stethoscope called ©CompuSteth to Diagnose Heart Disease

    Rochester, MN

  3. Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

    Scottsdale/Phoenix, AZ

  4. A Study to Evaluate the Effectiveness and Safety of Remdesivir to Treat Coronavirus Disease 2019 in an Outpatient Setting

    Rochester, MN

  5. Cardio-Oncology Clinic Registry

    Rochester, MN

  6. A Study of Biomarkers to Predict Cancer Therapy-related Cardiotoxicity

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. Cardiotoxic Effects of Chemotherapy in Patients with Sarcomas

    Rochester, MN

  8. Is Our Microbiome a Predictor of Cardiac Risk

    Rochester, MN

  9. Genotype-Phenotype Correlation in Cardiovascular Disease

    Rochester, MN

  10. Exercise during Heart Cath in CHD Patients

    Rochester, MN

.

Mayo Clinic Footer